ROS-mediated SRMS activation confers platinum resistance in ovarian cancer. Jiang Y, Song L, Lin Y, Nowialis P, et al. Oncogene 2023 Apr 5. doi: 10.1038/s41388-023-02679.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jiang Y, Song L, Lin Y, Nowialis P, et al. ROS-mediated SRMS activation confers platinum resistance in ovarian cancer. Oncogene 2023 Apr 5. doi: 10.1038/s41388-023-02679.
PMID: 37020040